URGENT ¥¥¥ Novartis condemns India patent ruling

Swiss drugs giant Novartis condemned on Monday the Indian Supreme Court's dismissal of its patent bid for a blockbuster cancer drug, saying it "discourages future innovation".

Novartis said in a statement the decision, which capped a seven-year legal battle to gain patent protection for an updated version of leukemia drug Glivec, "discourages innovative drug discovery essential to advancing medical science for patients".